GLS and Burkitt lymphoma: Consistent with this effect, in independent studies, AZD3965 and IACS-010759 have been combined with the glutaminase inhibitor BPTES, and increased in vitro sensitivity observed in BL and Mantle cell lymphoma cell lines respectively [6, 18].